Topiramate
NDC 70518-0625, Topiramate, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-0625
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076343
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE25 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0625-1 | 70518062501 | 30 POUCH in 1 BOX, UNIT-DOSE (70518-0625-1) / 1 TABLET in 1 POUCH (70518-0625-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0cf388dc-d8f1-4478-bf5f-e64638ee5801
Use it
Look up 70518-0625 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.